BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 1670840)

  • 1. Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris.
    Kragballe K; Gjertsen BT; De Hoop D; Karlsmark T; van de Kerkhof PC; Larkö O; Nieboer C; Roed-Petersen J; Strand A; Tikjøb G
    Lancet; 1991 Jan; 337(8735):193-6. PubMed ID: 1670840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
    Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM
    Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group.
    Molin L; Cutler TP; Helander I; Nyfors B; Downes N
    Br J Dermatol; 1997 Jan; 136(1):89-93. PubMed ID: 9039301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris.
    Cunliffe WJ; Berth-Jones J; Claudy A; Fairiss G; Goldin D; Gratton D; Henderson CA; Holden CA; Maddin WS; Ortonne JP
    J Am Acad Dermatol; 1992 May; 26(5 Pt 1):736-43. PubMed ID: 1583173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial.
    Guenther L; Van de Kerkhof PC; Snellman E; Kragballe K; Chu AC; Tegner E; Garcia-Diez A; Springborg J
    Br J Dermatol; 2002 Aug; 147(2):316-23. PubMed ID: 12174105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcipotriol ointment. A review of its use in the management of psoriasis.
    Scott LJ; Dunn CJ; Goa KL
    Am J Clin Dermatol; 2001; 2(2):95-120. PubMed ID: 11705309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of calcipotriol solution (50 micrograms/ml) and betamethasone 17-valerate solution (1 mg/ml) in the treatment of scalp psoriasis.
    Klaber MR; Hutchinson PE; Pedvis-Leftick A; Kragballe K; Reunala TL; Van de Kerkhof PC; Johnsson MK; Molin L; Corbett MS; Downess N
    Br J Dermatol; 1994 Nov; 131(5):678-83. PubMed ID: 7999600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of calcipotriol monotherapy and a combination of calcipotriol and betamethasone valerate after 2 weeks' treatment with calcipotriol in the topical therapy of psoriasis vulgaris: a multicentre, double-blind, randomized study.
    Ruzicka T; Lorenz B
    Br J Dermatol; 1998 Feb; 138(2):254-8. PubMed ID: 9602870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new calcipotriol/betamethasone dipropionate formulation (Daivobet) is an effective once-daily treatment for psoriasis vulgaris.
    Kaufmann R; Bibby AJ; Bissonnette R; Cambazard F; Chu AC; Decroix J; Douglas WS; Lowson D; Mascaro JM; Murphy GM; Stymne B
    Dermatology; 2002; 205(4):389-93. PubMed ID: 12444337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcipotriol-betamethasone ointment versus calcipotriol ointment in the treatment of psoriasis vulgaris.
    Duweb G; Alhaddar J; Elsherif B; Eljehawi N; Makhlouf H
    Drugs Exp Clin Res; 2005; 31(5-6):175-9. PubMed ID: 16425973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind, placebo-controlled, randomized, right-left study comparing calcipotriol monotherapy with a combined treatment of calcipotriol and diflucortolone valerate in chronic plaque psoriasis.
    Salmhofer W; Maier H; Soyer HP; Hönigsmann H; Hödl S
    Acta Derm Venereol Suppl (Stockh); 2000; (211):5-8. PubMed ID: 11234559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: a randomised, double-blind trial.
    Ortonne JP; Kaufmann R; Lecha M; Goodfield M
    Dermatology; 2004; 209(4):308-13. PubMed ID: 15539894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacy.
    Kragballe K; Barnes L; Hamberg KJ; Hutchinson P; Murphy F; Møller S; Ruzicka T; Van De Kerkhof PC
    Br J Dermatol; 1998 Oct; 139(4):649-54. PubMed ID: 9892908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris.
    Douglas WS; Poulin Y; Decroix J; Ortonne JP; Mrowietz U; Gulliver W; Krogstad AL; Larsen FG; Iglesias L; Buckley C; Bibby AJ
    Acta Derm Venereol; 2002; 82(2):131-5. PubMed ID: 12125943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of psoriasis vulgaris with the two-compound product calcipotriol/betamethasone dipropionate followed by different formulations of calcipotriol.
    Cassano N; Miracapillo A; Coviello C; Loconsole F; Bellino M; Vena GA
    Clin Drug Investig; 2006; 26(4):227-33. PubMed ID: 17163256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low incidence of hypercalcemia following combined calcipotriol hydrate/betamethasone dipropionate ointment treatment in Japanese patients with severe psoriasis vulgaris.
    Morita A; Muramatsu S; Kubo R; Ikumi K; Sagawa Y; Saito C; Torii K; Nishida E
    J Dermatolog Treat; 2018 Aug; 29(5):496-500. PubMed ID: 29076379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-life effectiveness of once-daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: 4- and 12-week interim results from the PRO-long study.
    Lambert J; Hol CW; Vink J
    J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1723-31. PubMed ID: 24533503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Betamethasone valerate dressing is non-inferior to calcipotriol-betamethasone dipropionate ointment in the treatment of patients with mild-to-moderate chronic plaque psoriasis: results of a randomized assessor-blinded multicentre trial.
    Ortonne JP; Esposito M; Chimenti S; Kapińska-Mrowiecka M; Grodzińska A; Naldi L; Frangione V
    J Eur Acad Dermatol Venereol; 2014 Sep; 28(9):1226-34. PubMed ID: 24256460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp.
    McCormack PL
    Drugs; 2011 Apr; 71(6):709-30. PubMed ID: 21504248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, safety, and cost-effectiveness of all-trans retinoic acid/Clobetasol Propionate Compound Ointment in the treatment of mild to moderate psoriasis vulgaris: A randomized, single-blind, multicenter clinical trial.
    Xia L; Li R; Wang Y; Lin Z; Zheng J; Li X; Lu Q; Zhang J; Jin H; Fu L; Zhang X; Liu Y; Yang S; Xiao F; Gao XH
    Dermatol Ther; 2018 Sep; 31(5):e12632. PubMed ID: 30253049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.